10 Stocks Under $1 That Will Explode

4. Oncolytics Biotech Inc. (NASDAQ:ONCY)

Share Price (As of January 8, 2026): $0.99

Upside Potential: 424.50%

Number of Hedge Fund Holders: 3

Oncolytics Biotech Inc. (NASDAQ:ONCY) is included in our list of the stocks under $1 that will explode.

Oncolytics Biotech Inc. (NASDAQ:ONCY) shared a leadership update on January 7, 2026. With the appointment of Dr. Eileen O’Reilly of Memorial Sloan Kettering Cancer Center, Dr. Neil Segal of MSK, and Dr. Van Morris of MD Anderson Cancer Center, the company expanded its Gastrointestinal (GI) Tumor Scientific Advisory Board. The clinical and strategic oversight is strengthened with the move, as the company advances pelareorep toward registration-enabling trials in pancreatic, colorectal, and anal cancers. Furthermore, management said that the expanded board sharpens the late-stage development strategy for a GI-focused immunotherapy platform with large addressable markets.

This leadership expansion follows the company’s clinical and translational momentum announced earlier in December. Data in second-line KRAS-mutant, microsatellite-stable metastatic colorectal cancer, showed a 33% objective response rate compared to a historical 6-11%. Furthermore, it showed more than doubling of progression-free and overall survival versus standard therapy. On the translational analysis front, increased KRAS-specific T-cell responses were reported, which reinforces pelareorep’s mechanistic differentiation.

Oncolytics Biotech Inc. (NASDAQ:ONCY) is focused on developing pelareorep, an immune-oncolytic virus platform targeting solid tumors and hematologic malignancies. It leverages tumor-selective viral replication to stimulate innate and adaptive anti-cancer immune responses.